Richard Ian Griffiths - 25 Jun 2025 SCHEDULE 13D/A Report for Silence Therapeutics Plc Ordinary Shares, nominal value of GBP0.05 per share

Filing Manager: Richard Ian Griffiths
Reporting Manager: Richard Ian Griffiths
Security: Silence Therapeutics Plc Ordinary Shares, nominal value of GBP0.05 per share
Shares outstanding: 141,570,910 shares
Disclosed Ownership: 34,543,302 shares
Ownership: 24%
Form type: SCHEDULE 13D/A
Filing time: 25 Jun 2025, 10:24:36 UTC
Date of event: 25 Jun 2025
Previous filing: 08 May 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Richard Ian Griffiths	24%	34,543,302	34,543,302	0	/s/ Richard Ian Griffiths	Richard Ian Griffiths	0001846370
Ora Capital Limited	14%	19,221,525	19,221,525	0	/s/ Richard Ian Griffiths	Director